Gynécologie & Obstétrique
Libre accès

Abstrait

Investigating the Efficacy of Mifepristone in First-Trimester Miscarriage Treatment: The MiFirsT Study

Juan Rodriguez

Miscarriage, a frequently encountered event during early pregnancy, presents significant physical and emotional challenges for women and couples. The management of first-trimester miscarriages has seen progressive advancements with the overarching goal of reducing complications and providing empathetic support. The MiFirsT study represents a pioneering double-blind randomized controlled trial, strategically crafted to assess the potential benefits of mifepristone in the treatment of first-trimester miscarriages. This research holds promise in enhancing the care and outcomes for individuals facing this distressing aspect of reproductive health.